InterMune crashes, drags down biotech index – MarketWatch

By Dr. Matthew Watson


TopNews Singapore (press release)
InterMune crashes, drags down biotech index
MarketWatch
InterMune's woes also weighed heavily on the NYSE Arca Biotechnology Index (INDEX:BTK) , of which InterMune is a leading component. ...
FDA rejects InterMune lung drug, shares fallReuters
InterMune's Surprise Rejection Leads Stock to PlummetBusinessWeek
InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone ...PR Newswire (press release)

all 189 news articles »



categoriaUncategorized commentoComments Off on InterMune crashes, drags down biotech index – MarketWatch | dataMay 6th, 2010

About...

This author published 5432 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2024